Page tree
Skip to end of metadata
Go to start of metadata

The START (Strategic Timing of Antiretroviral Treatment) study, conducted in 2011–2016, showed the benefits of beginning anti-retroviral therapy at the moment of HIV diagnosis, rather than waiting for signs of the progression of HIV infection via CD4+/CD8+ counts.

Found 4 search result(s) for "Strategic Timing".

Page: TEMPRANO study (2008–2015) (HIV/AIDS Research: Its History & Future Meeting)
... would result in better AIDS outcomes. The results of TEMPRANO along with those of START (Strategic Timing of Antiretroviral Treatment) study, 2011–2016 led to the adoption of early, asymptomatic ART ...
Jan 05, 2021
Page: 2.3 Mark Harrington — The Importance of Activism to the US Response (HIV/AIDS Research: Its History & Future Meeting)
... PrEP), and SMART (Strategies for Management of AntiRetroviral Therapy study, 2002–2006) and START (Strategic Timing of Antiretroviral Treatment study, 2011–2016), which led to the recommendation to treat all ... ...
Apr 27, 2021
Page: 2.6 Tony Fauci — 35 Years of HIV/AIDS: Science and Policy (HIV/AIDS Research: Its History & Future Meeting)
... Strategies for Management of AntiRetroviral Therapy study, 2002–2006), HPTN 052, START (Strategic Timing of Antiretroviral Treatment study, 2011–2016) answering the question. It's better to be on antiretroviral ...
Apr 27, 2021
Page: 3.6 John C. Martin — Making it Simpler: A Single Pill to Treat HIV (HIV/AIDS Research: Its History & Future Meeting)
... Stanford University School of Medicine, Stanford University Medical Center https://libwiki.cshl.edu/confluence/display/AT/StanfordUniversity%2CStanfordUniversitySchoolofMedicine%2CStanfordUniversityMedicalCenter  START (Strategic Timing of Antiretroviral Treatment) study, 2011–2016 https://libwiki.cshl.edu/confluence/pages/viewpage.action?pageId=15532297  tablet press https://libwiki.cshl.edu/confluence/display/AT/tabletpress  TEMPRANO ...
Apr 27, 2021

  • No labels